A new device to prevent infections and blockages in vascular catheters
Official title: BIOACTIVE LUMINAL INSERT TO REDUCE CATHETER INFECTIONS AND THROMBOTIC OCCLUSIONS
Funded at Cathpro Technologies LLC · NIH-10919724 · Data updated 2026-11-12
This study is testing a new device that helps keep hospital catheters clean and clear, making them safer and more effective for patients who need treatments or nutrition through these tubes.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cathpro Technologies LLC NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project start | May 1, 2024 |
| Project end | December 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $310,170 |
| NIH project number | 1R43HL172566-01A1 |
| Project ID | NIH-10919724 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients who require long-term vascular access for therapies, such as those undergoing chemotherapy or critical care.
✕Less likely to help
Patients who do not require vascular catheters or those with short-term access needs may not benefit from this research.
What this research studies
This research focuses on developing a novel device designed to reduce infections and blockages in vascular catheters, which are commonly used for administering therapies and nutrition in hospitals. The device combines anti-infective and anti-thrombotic technologies to provide long-term protection against microbial colonization and thrombotic occlusions. By addressing the limitations of existing products, this research aims to enhance the safety and effectiveness of vascular access procedures. Patients may benefit from improved outcomes and reduced complications associated with catheter use.
Why it matters
Potential benefit: If successful, this research could significantly lower the risk of infections and blockages for patients requiring vascular access, leading to safer treatment experiences.
How similar studies have gone: While there are existing products aimed at preventing catheter-related complications, this approach is novel and seeks to provide a more comprehensive solution than current options.
Where this research is happening
-
Cathpro Technologies LLC
Salt Lake City, United States Active
Researchers
- Principal investigator: Thiagarajan, Giridhar — Cathpro Technologies LLC
- Study coordinator: Thiagarajan, Giridhar
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.